Skip to content

CHIROG

Active
Private limited companyfounded 2018active for 8 yearsHeistraat 16, 9052 Gent, BelgiumKBO/BCE: BE 0699.953.384

Financials · financial year 2025, micro format

Annual accounts 2025 filed on 03-07-2026 at the NBB all 7 filings

Turnover
≈ €490,000
Estimated: probably between €440,000 and €610,000
Total assets
€624,433▲ 20.8%
2024 · €517,101
Net result
€96,215▲ 28.6%
2024 · €74,814
Working capital
€35,795
2024 · -€38,395
Trend over the years

2021 to 2025, 5 financial years 2019 to 2025, 7 financial years

The operating result for 2025 is 36% higher than in 2024 and the highest since 2021. It is the third rise in a row, after the fall in 2022.

Operating result€136,611 2025 Net result€96,215 2025

Turnover is what the company sold, the result is what was left of it. A loss stands below the zero line.

Use the arrow keys on the chart for the figures per year.

The sector band is the middle half of the companies in Human health activities (NACE 86). A quarter of them sit below it, a quarter above. Each year counts only accounts in the same format, and only where there are at least 30. The dashed line is the median. There is a sector band for net result, equity, total assets, working capital, solvency, current ratio, return on assets (ROA) and staff (FTE).

Every figure with its change against the financial year before
favourable unfavourable
Line2019202020212022202320242025
Operating result-€61,590--€41,091▲ 33.3%-€19,261▲ 53.1%-€29,964▼ 55.6%€85,721€100,376▲ 17.1%€136,611▲ 36.1%
Net result-€67,383--€49,743below the sector's middle half▲ 26.2%-€25,615below the sector's middle half▲ 48.5%-€38,331below the sector's middle half▼ 49.6%€75,955within the sector's middle half€74,814within the sector's middle half▼ 1.5%€96,215within the sector's middle half▲ 28.6%
Equity-€54,983--€104,726below the sector's middle half▼ 90.5%-€130,342below the sector's middle half▼ 24.5%-€168,673below the sector's middle half▼ 29.4%-€92,718below the sector's middle half▲ 45.0%-€17,905below the sector's middle half▲ 80.7%€78,310within the sector's middle half
Total assets€760,181-€594,057within the sector's middle half▼ 21.9%€501,439within the sector's middle half▼ 15.6%€418,604within the sector's middle half▼ 16.5%€353,271within the sector's middle half▼ 15.6%€517,101within the sector's middle half▲ 46.4%€624,433above the sector's middle half▲ 20.8%
Debt€815,164-€698,784▼ 14.3%€631,780▼ 9.6%€587,277▼ 7.0%€445,989▼ 24.1%€535,006▲ 20.0%€546,123▲ 2.1%
Working capital-€485,679--€201,929below the sector's middle half▲ 58.4%-€178,246below the sector's middle half▲ 11.7%-€167,721below the sector's middle half▲ 5.9%-€64,774below the sector's middle half▲ 61.4%-€38,395below the sector's middle half▲ 40.7%€35,795within the sector's middle half
Solvency-7.2%--17.6%below the sector's middle half▼ 10.4pp-26.0%below the sector's middle half▼ 8.4pp-40.3%below the sector's middle half▼ 14.3pp-26.2%below the sector's middle half▲ 14.0pp-3.5%below the sector's middle half▲ 22.8pp12.5%below the sector's middle half▲ 16.0pp
Current ratio0.25-0.32below the sector's middle half▲ 0.070.36below the sector's middle half▲ 0.040.40below the sector's middle half▲ 0.050.66below the sector's middle half▲ 0.250.88below the sector's middle half▲ 0.221.09below the sector's middle half▲ 0.21
Return on assets (ROA)-8.9%--8.4%below the sector's middle half▲ 0.5pp-5.1%below the sector's middle half▲ 3.3pp-9.2%below the sector's middle half▼ 4.0pp21.5%within the sector's middle half▲ 30.7pp14.5%within the sector's middle half▼ 7.0pp15.4%within the sector's middle half▲ 0.9pp
Staff (FTE)0.9-1within the sector's middle half▲ 11.1%1=1=0.7▼ 30.0%0.8▲ 14.3%1▲ 25.0%
above within below The sector band is the middle half of the companies in Human health activities (NACE 86). A quarter of them sit below it, a quarter above. Each year counts only accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin are not published. The abbreviated or micro format does not require them. The turnover shown is an estimate from the gross margin.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €624,433
Fixed assets €198,369 ▼ 13.5%
Current assets €426,064 ▲ 48.1%
Equity and liabilities €624,433
Equity €78,310
Debt €546,123
Debt's share of the balance-sheet total is 87.5%.
Key figures and ratios
2025 value · change against 2024
EBITDA
€197,650▲
2024 · €155,226
Cash flow
€157,254▲
2024 · €129,663
Debt to equity
6.97
ROE
122.9%
Interest coverage
40.32▲
2024 · 31.49
Debt ≤ 1 year
€390,268▲
2024 · €326,143
Debt > 1 year
€155,854▼
2024 · €208,863
Income taxes
€35,649▲
2024 · €20,774
Staff costs
€99,876▲
2024 · €58,165
Green means a favourable move, even when the figure itself falls, as with debt or debt to equity.

Comparable companies

These companies have the same main activity as CHIROG: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €561,000 and €725,000, founded between 2018 and 2019.

CompanyFoundedTotal assetsEquityGross marginNet resultFinancial year
CHIROG Gent2018€624,433€78,310€314,366€96,2152025
Dr. Isabelle Fonteyne Gent2018€612,999€251,907€320,471€155,4202025
DR. WITTERS I. ANESTHESIE Gent2018€676,874€245,176€322,718€226,3212025
Dokter Jonas Verzele Gent2019€561,117€221,565€317,188€202,4752025
Dr.Ph.Moyaert, Anesthesist Maldegem2019€581,827€144,937€315,661€231,6482025
DOKTER KOEN LAPAGE-ANESTHESIE Kruisem2018€724,992€103,697€304,506€216,8932025
Dr. Thomas De Bo, orthopedist Aalter2019€573,853€164,764€342,801€213,8442025

They were chosen from the 8,159 other active companies with that main activity and annual accounts from the past two years. All companies with this main activity

Companies with the same profile, two years later

Historical observation

In July 2024, 6,713 companies had the same profile as CHIROG has now. Two years later, 1.8% had gone bankrupt and 95.8% were still going.

  • Micro
  • 5 to 10 years old
  • solvency 10 to 30%
  • a profit of 5% of the balance sheet or more
1.8% went bankrupt
2.2% stopped otherwise
95.8% was still going

Another 0.2% stopped without a precise date, possibly only after those two years.

The bankruptcy probability of CHIROG itself is lower: 0.1% within 12 months. It rests on far more data about CHIROG than the profile alone.

Test of the method

The method was tested on the 497,445 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 6,713 companies, not a prediction for CHIROG. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Subsidies and aid

Flemish government

2025 · 1 entry · €600 awarded · €600 paid
Schemes
1 entry · €600 · €600 paid · Fonds voor Innoveren en Ondernemen
Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 46 lines

Source: Annual accounts 2025 at the NBB, filed on 03-07-2026.

Balance sheet Code20242025
Assets
Total assets20/58€517,101€624,433▲
Fixed assets21/28€229,354€198,369▼
Intangible fixed assets21€176,849€126,849▼
Tangible fixed assets22/27€27,475€46,489▲
Plant, machinery and equipment23€4,950€24,806▲
Furniture and vehicles24€22,525€21,684▼
Financial fixed assets28€25,030€25,030=
Current assets29/58€287,747€426,064▲
Amounts receivable within one year40/41€59,657€101,751▲
Other amounts receivable41€59,657€101,751▲
Cash at bank and in hand54/58€36,219€70,880▲
Deferred charges and accrued income490/1€191,871€253,433▲
Equity and liabilities
Total equity and liabilities10/49€517,101€624,433▲
Equity10/15-€17,905€78,310▲
Contributions10/11€12,400€12,400=
Reserves13-€65,910
Distributable reserves133-€65,910
Profit (loss) carried forward14-€30,305€0▲
Amounts payable17/49€535,006€546,123▲
Amounts payable after more than one year17€208,863€155,854▼
Financial debts170/4€208,863€155,854▼
Amounts payable within one year42/48€326,143€390,268▲
Current portion of amounts payable after more than one year42€50,065€50,601▲
Trade debts44€56,643€68,933▲
Suppliers440/4€56,643€68,933▲
Taxes, remuneration and social security45€38,639€103,562▲
Taxes450/3€37,818€92,422▲
Remuneration and social security454/9€821€11,140▲
Other amounts payable47/48€180,795€167,172▼
Income statement Code20242025
Remuneration, social security and pensions62€58,165€99,876▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€54,850€61,039▲
Other operating charges640/8€673€16,840▲
Gross operating margin9900€214,063€314,366▲
Operating profit (loss)9901€100,376€136,611▲
Financial income75/76B€141€156▲
Recurring financial income75€141€156▲
Financial charges65/66B€4,930€4,902▼
Recurring financial charges65€4,930€4,902▼
Profit (loss) for the period before taxes9903€95,587€131,864▲
Income taxes67/77€20,774€35,649▲
Profit (loss) for the period9904€74,814€96,215▲
Profit (loss) for the period to be appropriated9905€74,814€96,215▲
Appropriation of the result
Profit (loss) to be appropriated9906-€30,305€65,910▲
Profit (loss) brought forward from the previous period14P-€105,118-€30,305▲
Transfer to equity691/2-€65,910
To other reserves6921-€65,910

The notes to these accounts have 14 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.

Line2019202020212022202320242025Change
Remuneration, social security and pensions62--€45,828€54,389€43,064€58,165€99,876▲ 71.7%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€145,272€99,362€98,833€98,337€76,349€54,850€61,039▲ 11.3%
Other operating charges640/8--€3,058€2,566€8,836€673€16,840▲ 25×
Gross operating margin9900€153,449€106,124€128,458€125,329€213,970€214,063€314,366▲ 46.9%
Operating profit (loss)9901-€61,590-€41,091-€19,261-€29,964€85,721€100,376€136,611▲ 36.1%
Financial income75/76B--€0€67€73€141€156▲ 10.2%
Recurring financial income75€3€6€0€67€73€141€156▲ 10.2%
Financial charges65/66B--€5,591€6,103€6,031€4,930€4,902▼ 0.6%
Recurring financial charges65€4,548€5,749€5,591€6,103€6,031€4,930€4,902▼ 0.6%
Profit (loss) for the period before taxes9903-€66,135-€46,834-€24,851-€36,000€79,763€95,587€131,864▲ 38.0%
Income taxes67/77€1,248€2,909€764€2,331€3,808€20,774€35,649▲ 71.6%
Profit (loss) for the period9904-€67,383-€49,743-€25,615-€38,331€75,955€74,814€96,215▲ 28.6%
Profit (loss) for the period to be appropriated9905-€67,383-€49,743-€25,615-€38,331€75,955€74,814€96,215▲ 28.6%
Line2019202020212022202320242025Change
Assets
Total assets20/58€760,181€594,057€501,439€418,604€353,271€517,101€624,433▲ 20.8%
Formation expenses20€2,216€1,589€963€336€0---
Fixed assets21/28€595,989€498,233€400,785€304,367€228,354€229,354€198,369▼ 13.5%
Intangible fixed assets21€426,849€376,849€326,849€276,849€226,849€176,849€126,849▼ 28.3%
Tangible fixed assets22/27€169,140€121,034€73,466€27,047€1,035€27,475€46,489▲ 69.2%
Plant, machinery and equipment23--€69,362€24,611€464€4,950€24,806▲ 401%
Furniture and vehicles24--€4,104€2,436€571€22,525€21,684▼ 3.7%
Financial fixed assets28-€350€470€470€470€25,030€25,030=
Current assets29/58€161,976€94,235€99,691€113,901€124,916€287,747€426,064▲ 48.1%
Amounts receivable within one year40/41-€10,440€1,050€1,056€3,779€59,657€101,751▲ 70.6%
Other amounts receivable41--€1,050€1,056€3,779€59,657€101,751▲ 70.6%
Cash at bank and in hand54/58€116,504€29,392€19,305€74,617€33,449€36,219€70,880▲ 95.7%
Deferred charges and accrued income490/1--€79,336€38,228€87,689€191,871€253,433▲ 32.1%
Equity and liabilities
Total equity and liabilities10/49€760,181€594,057€501,439€418,604€353,271€517,101€624,433▲ 20.8%
Equity10/15-€54,983-€104,726-€130,342-€168,673-€92,718-€17,905€78,310-
Contributions10/11€12,400-€12,400€12,400€12,400€12,400€12,400=
Reserves13------€65,910-
Distributable reserves133------€65,910-
Profit (loss) carried forward14-€67,383-€117,126-€142,742-€181,073-€105,118-€30,305€0-
Amounts payable17/49€815,164€698,784€631,780€587,277€445,989€535,006€546,123▲ 2.1%
Amounts payable after more than one year17€167,510€402,620€353,843€305,655€256,298€208,863€155,854▼ 25.4%
Financial debts170/4--€353,843€305,655€256,298€208,863€155,854▼ 25.4%
Amounts payable within one year42/48€647,654€296,164€277,937€281,622€189,691€326,143€390,268▲ 19.7%
Current portion of amounts payable after more than one year42--€48,777€48,682€49,357€50,065€50,601▲ 1.1%
Trade debts44€40,696€42,161€50,975€85,187€33,756€56,643€68,933▲ 21.7%
Suppliers440/4--€50,975€85,187€33,756€56,643€68,933▲ 21.7%
Advances received on contracts in progress46---€29,600€0---
Taxes, remuneration and social security45--€10,703€19,872€24,380€38,639€103,562▲ 168%
Taxes450/3--€10,703€13,848€22,671€37,818€92,422▲ 144%
Remuneration and social security454/9---€6,024€1,709€821€11,140▲ 14×
Other amounts payable47/48--€167,483€98,281€82,198€180,795€167,172▼ 7.5%
Line2019202020212022202320242025Change
Profit (loss) for the period9904-€67,383-€49,743-€25,615-€38,331€75,955€74,814€96,215▲ 28.6%
+ Depreciation and write-downs630€145,272€99,362€98,833€98,337€76,349€54,850€61,039▲ 11.3%
Operating cash flow (approximation)€77,889€49,619€73,218€60,006€152,303€129,663€157,254▲ 21.3%
Investment in fixed assets (approximation)--€1,606-€1,385-€1,919-€336-€55,850-€30,054▲ 46.2%
Change in cash--€87,112-€10,088€55,312-€41,168€2,770€34,661▲ 13×

A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.

Download as CSV

Filings with the National Bank (7)
Financial year Type Filed Reference Document
31-12-2025 micro format 03-07-2026 2026-00245923 NBB
31-12-2024 micro format 18-06-2025 2025-00148901 PDF
31-12-2023 micro format 27-09-2024 2024-00475419 PDF
31-12-2022 micro format 06-10-2023 2023-00479794 PDF
31-12-2021 micro format 29-09-2022 2022-20441220 PDF
31-12-2020 micro format 31-08-2021 2021-62300046 PDF
31-12-2019 abbreviated format 18-08-2020 2020-42800587 PDF

Next steps